The novel pathway and classification of Korean steatohepatitis progressio
Not Applicable
Active, not recruiting
- Conditions
- Diseases of the digestive system
- Registration Number
- KCT0003579
- Lead Sponsor
- Korea University Anam Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
patients with abnormal serum AST or ALT or bilirubin levels for more than three months, who agreed to undergo liver tissue examination to determine the cause
Person who voluntarily decided to participate in this clinical trial and signed the consent form
Exclusion Criteria
- Excessive drinker (male, state > 140g; female, state > 70g)
- Drug users who may cause hepatotoxicity or statosis
- Non-targeted liver cirrhosis patient
- Patients suffering from malignant tumors/systemic diseases
- Pregnant patient
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Differences in RNA Expressions by NAFLD stage
- Secondary Outcome Measures
Name Time Method Differences in Non-invasive Test According to Regional Progress